Koji Product Supplementation' s Study (KPS)
27. června 2021 aktualizováno: National Taiwan University Hospital
The Effect of Black Soybeans Koji Product Supplementation on Nutrients Absorption and Anti-aging Effect in Elderly
The present project is to identify the effect of black soy beans Koji product supplementation on nutrients absorption and anti-aging effect in elderly.
Přehled studie
Postavení
Dokončeno
Podmínky
Intervence / Léčba
Detailní popis
Previous studies show that supplementation of soy protein can effectively increase muscle mass and protein utilization.
Besides, soy extracts and isoflavones can stimulate muscle growth by activating the anabolic pathway of muscle tubules.
Black soybean is known to be rich in legume protein and isoflavones.We speculate that black soybean supplementation can improve the nutritional status and muscle mass of elderly people, thereby delaying the deterioration of muscular dystrophy in the elderly.
Reduce the occurrence of debilitation in the elderly.
Typ studie
Intervenční
Zápis (Aktuální)
60
Fáze
- Nelze použít
Kontakty a umístění
Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.
Studijní místa
-
-
-
Taipei City, Tchaj-wan, 110
- Taipei Medical University
-
-
Kritéria účasti
Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dítě
- Dospělý
- Starší dospělý
Přijímá zdravé dobrovolníky
Ano
Pohlaví způsobilá ke studiu
Všechno
Popis
Inclusion Criteria:
1-2 items are necessary, 3-5 can match one item
- Age above 65 years
- Oral intake
- Walking speed: ≤ 0.8 m/s (measured by time for a 5-meter usual gait)
- Handgrip strength: Men: <26 kg Women: <18 kg (measured by electronic hand grip dynamometer)
- Calf circumference: Men: ≤ 34 cm Women: ≤ 33 cm
Exclusion Criteria:
- Participant in a moderate or strenuous exercise
- Unable to walk
- Unable to take in food from the mouth
- People who can't record or communicate.
- Refuse to accept the 3-day diet record
- Allergic to black soybeans or legumes
- Allergic to egg or milk
- Infected with disease and had to be hospitalized for treatment before 4 weeks of the intervention test start
- A patient who has been diagnosed with a malignant tumor or has a history of malignancy in the past year.
- The estimated glomerular filtration rate (eGFR) is less than 60 ml/min/1.73 m2 in the past three months.
- Hypothyroidism
- People who often have symptoms of gastrointestinal upset.
Studijní plán
Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.
Jak je studie koncipována?
Detaily designu
- Primární účel: Prevence
- Přidělení: N/A
- Intervenční model: Přiřazení jedné skupiny
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Black soybean koji product
Oral supplement 2 servings of black soybean koji product per day, for 10 weeks.
|
Black soybean koji product
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Body mass index
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Measure Participants' detected body composition by using bioelectrical impedance analysis (BIA) as a non-invasive test instrument to measure body mass index (BMI).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Fat mass
Časové okno: Change from baseline outcome measure at 10th week (post-test).
|
Measure Participants' detected body composition by using bioelectrical impedance analysis (BIA) as a non-invasive test instrument to measure fat mass.
|
Change from baseline outcome measure at 10th week (post-test).
|
|
Muscle mas
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Measure Participants' detected body composition by using bioelectrical impedance analysis (BIA) as a non-invasive test instrument to measure whole body and appendicular skeletal muscle mass.
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Visceral fat area(VFA)
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Measure Participants' detected body composition by using bioelectrical impedance analysis (BIA) as a non-invasive test instrument to measure Visceral fat area(VFA) (cm2).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
BIA - Basal Metabolic Rate(BMR)
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Measure Participants' detected body composition by using bioelectrical impedance analysis (BIA) as a non-invasive test instrument to measure Basal Metabolic Rate(BMR) (kcal) . |
Change from baseline outcome measure at 10th week (post-test)
|
|
whole body Mineral
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Measure Participants' detected body composition by using bioelectrical impedance analysis (BIA) as a non-invasive test instrument to measure Mineral (kg) in whole body. . |
Change from baseline outcome measure at 10th week (post-test)
|
|
Bone Mineral Content
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Measure Participants' detected body composition by using bioelectrical impedance analysis (BIA) as a non-invasive test instrument to measure Bone Mineral Content (kg).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Cellular Water
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Measure Participants' detected body composition by using bioelectrical impedance analysis (BIA) as a non-invasive test instrument to measure whole body Extracellular Water (L), Intracellular Water(L), and Total Body Water (L), et al. . |
Change from baseline outcome measure at 10th week (post-test)
|
|
Muscle Strength - Hand Grip Strength
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Using hand grips to measure hand grip strength.
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Physical Performance - Walking Speed
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Measuring participants' speed to walk 5 ft.
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Gut Microbiota Composition Analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Total genome DNA from samples was extracted from stool samples using the CTAB/SDS method.
One hundred ng of DNA was amplified with barcoded primers16S V3+V4: 314F-806R annealing to the V3-V4region of the 16S rRNA.
All of the PCR reactions were carried out using a Phusion® High-Fidelity PCR Master Mix (New England Biolabs, Location).
Samples with a bright main strip between 400 and 450bp were selected from 2% agarose gel for further experiments.
Mixture PCR products were purified using a Qiagen Gel Extraction Kit (Qiagen, Germany).
Libraries were generated with the TruSeq® DNA PCR-Free Sample Preparation Kit and quantified with Qubit and Q-PCR.
The purified DNA was then sequenced using the HiSeq2500 PE250 (Company, Location).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Gut Microbiota -derived Metabolite Analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Measurements of short-chain fatty acids in feces during the experiment by using gas chromatography.
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Inflammatory Cytokines TNF-α Analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
The inflammation-associated serum cytokines TNF-α was analyzed using colorimetric kits (Company, Location).
Thioredoxin (Cloud-Clone Corp, SEA702Hu, City, State, USA) and Complement Component 5a (Cloud-Clone Corp, SEA388Hu) in the urine was evaluated for the effects of inflammation states and also assessed using colorimetric kits.
The procedures followed the kit instructions and were measured using an ELISA reader (Bio Tek, PowerWave XS2, City, State, USA).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Inflammatory Cytokines IL-6 Analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
The inflammation-associated serum cytokines IL-6 was analyzed using colorimetric kits (Company, Location).
Thioredoxin (Cloud-Clone Corp, SEA702Hu, City, State, USA) and Complement Component 5a (Cloud-Clone Corp, SEA388Hu) in the urine was evaluated for the effects of inflammation states and also assessed using colorimetric kits.
The procedures followed the kit instructions and were measured using an ELISA reader (Bio Tek, PowerWave XS2, City, State, USA).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Inflammatory Cytokines IL-1β Analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
The inflammation-associated serum cytokines IL-1β (BioLegend, City, State, USA) was analyzed using colorimetric kits (Company, Location).
Thioredoxin (Cloud-Clone Corp, SEA702Hu, City, State, USA) and Complement Component 5a (Cloud-Clone Corp, SEA388Hu) in the urine was evaluated for the effects of inflammation states and also assessed using colorimetric kits.
The procedures followed the kit instructions and were measured using an ELISA reader (Bio Tek, PowerWave XS2, City, State, USA).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Red blood cells analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of red blood cells( M/ul)
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Hemoglobin analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of Hemoglobin(g/dL).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
MCHC(g/dL) analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of MCHC(g/dL)
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Albumin analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of albumin(g/dL).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Hematocrit analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of Hematocrit(%).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
RDW-CV analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of RDW-CV(%).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
HbA1C analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of HbA1C(%).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
MCV analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of MCV(fL).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
MCH analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of MCH(pg).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Platelets analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of Platelets(k/uL).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
WBC analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of WBC(k/uL) .
|
Change from baseline outcome measure at 10th week (post-test)
|
|
AST analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of AST(U/L).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
ALT analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of ALT(U/L).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
GGT analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of GGT(U/L).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
T-Cholesterol analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of T-Cholesterol(mg/dL).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Triglyceride analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of triglyceride(mg/dL).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
BUN analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of BUN(mg/dL).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Uric acid analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of Uric acid(mg/dL).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
HDL-C analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of HDL-C(mg/dL).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
LDL-C analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of LDL-C(mg/dL).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
hs-CRP analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of hs-CRP(mg/dL).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Fasting blood glucose analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of fasting blood glucose(mg/dL).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Creatinine analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of creatinine(mg/dL).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Free T4 analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of 【Free T4(ng/dL)】
|
Change from baseline outcome measure at 10th week (post-test)
|
|
hsTSH analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of 【hsTSH(ulU/dL)】
|
Change from baseline outcome measure at 10th week (post-test)
|
|
HOMA-IR analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of 【 HOMA-IR】
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Insulin analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of 【 insulin(uU/dL)】
|
Change from baseline outcome measure at 10th week (post-test)
|
|
eGFR analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of 【eGFR (mL/min/1.73^2)】
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Ca analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Use the Clinical Chemistry Analyzer to detection of Ca(mmol/dL).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
specific gravity index analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Fasting for 8 hours, collecting 10ml urine.
Routine urine analysis which includes specific gravity index (USG).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Urine pH analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Fasting for 8 hours, collecting 10ml urine.
Routine urine analysis which includes pH.
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Urine total protein analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Fasting for 8 hours, collecting 10ml urine.
Routine urine analysis which includes Total protein (mg/dL).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Urine glucose analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Fasting for 8 hours, collecting 10ml urine.
Routine urine analysis which includes glucose (-/+).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Urine Urea Nitrogen analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Fasting for 8 hours, collecting 10ml urine.
Routine urine analysis which includes Urine Urea Nitrogen(-/+).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Urine ketones analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Fasting for 8 hours, collecting 10ml urine.
Routine urine analysis which includes ketones(-/+).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Urine Creatinine analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Fasting for 8 hours, collecting 10ml urine.
Routine urine analysis which includes Creatinine(mg/dL).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Urine bilirubin (dipstick) analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Fasting for 8 hours, collecting 10ml urine.
Routine urine analysis which includes bilirubin (-/+).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Urine Albumin analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Fasting for 8 hours, collecting 10ml urine.
Routine urine analysis which includes Albumin(mg/L).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Urine Albumin/Creatinine analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Fasting for 8 hours, collecting 10ml urine.
Routine urine analysis which includes Albumin/Creatinine(mg/g).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Urine Nitrite (dipstick) analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Fasting for 8 hours, collecting 10ml urine.
Routine urine analysis which includes Nitrite(-/+).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Urine WBC esterase analysis
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Fasting for 8 hours, collecting 10ml urine.
Routine urine analysis which includes WBC esterase(-/+).
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Superoxide dismutase (SOD) Oxidative stress assessment
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Oxidative stress assessment to assess Superoxide dismutase (SOD) in serum was measured by the ELISA kit.
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Glutathione peroxidase (GPx) Oxidative stress assessment
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Oxidative stress assessment to assess Glutathione peroxidase (GPx) in serum was measured by the ELISA kit..
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Catalase Oxidative stress assessment
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Oxidative stress assessment to assess Catalase in serum was measured by the ELISA kit..
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Physical examination-Height
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Measure participants' height.
The height measurement method is to measure after you take off your shoes and step on the machine.
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Physical examination- Body weight
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Measure participants' body weight.
The body weight measurement method is to measure after you take off your shoes and step on the weight machine.
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Physical examination - waist circumference
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Measure participants' waist circumference.
The waist measurement method is to use a tape measure to measure the waist circumference above the human hips.
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Physical examination - arm circumference
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Measure participants' arm circumference.
The measurement method of the arm circumference is the circumference of the upper arm and is measured at the mid-point between the tips of the shoulder and elbow. .
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Physical examination - calf circumference
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Measure participants' calf circumference.
The measurement method of the calf circumference should be the same as the shoulder width and place the tape measure at the thickest part of the calf with a horizontal line around it for measurement.
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Physical examination - hip circumference
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Measure participants' hip circumference.
The hip measurement method is to use a tape measure to measure the maximum hip diameter.
|
Change from baseline outcome measure at 10th week (post-test)
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Physical Activity Questionnaire assessment
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Using Physical Activity Questionnaire to assess participants' activity level.
|
Change from baseline outcome measure at 10th week (post-test)
|
|
24-hour Dietary Recall Form
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
The 24-hour diet recall method is conducted by interviewers who have received professional training in food serving size.
Ask participants to recall all food and beverages actually consumed in the past 24 hours and record them in the questionnaire.
Location, and the name, material, quantity and preparation method of food; among them, the estimation of the quantity can be assisted by using food weighing tools and food quantitative aids.
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Gastrointestinal Function Assessment
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
Assess the number of bowel movements, bowel habits, bowel pattern, and flatulence
|
Change from baseline outcome measure at 10th week (post-test)
|
|
Mini nutrition assessment
Časové okno: Change from baseline outcome measure at 10th week (post-test)
|
This Mini nutrition assessment is a Indicator of nutrition status .The score range from 0-30,24 to 30 points represent Normal nutritional status, 17 to 23.5 points represent At the risk of malnutrition, less than 17 points represent Malnourished.
|
Change from baseline outcome measure at 10th week (post-test)
|
Spolupracovníci a vyšetřovatelé
Zde najdete lidi a organizace zapojené do této studie.
Vyšetřovatelé
- Studijní židle: Hui-Yu Huang, Ph.D, Taipei Medical University Graduate Institute of Metabolism and Obesity Sciences
Termíny studijních záznamů
Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.
Hlavní termíny studia
Začátek studia (Aktuální)
12. října 2018
Primární dokončení (Aktuální)
30. června 2020
Dokončení studie (Aktuální)
30. června 2020
Termíny zápisu do studia
První předloženo
15. dubna 2019
První předloženo, které splnilo kritéria kontroly kvality
27. června 2021
První zveřejněno (Aktuální)
7. července 2021
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
7. července 2021
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
27. června 2021
Naposledy ověřeno
1. června 2021
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- 201806058RINA
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Ne
Studuje produkt zařízení regulovaný americkým úřadem FDA
Ne
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .